International Trade Bulletin - Volume 1, Issue 6
Client Alert | 1 min read | 05.30.06
Inside this issue:
- EUROPE IN THE SPOTLIGHT
- INTERNATIONAL LABOR & EMPLOYMENT LAW IN THE SPOTLIGHT
- U.S. Sex Harassment and Retaliation Law: Toyota has been hit with a lawsuit seeking $190 million in damages arising out of a claim of sex harassment filed against the company and its former top U.S. executive
- EU Employee's Rights: Companies Engaging in Mergers and Acquisitions in Europe Must Pay Close Attention to Employees' Rights
- ANTI-DUMPING: The Court of International Trade (CIT) confirms U.S. antidumping application of the revised reseller rule
- CHINA: Exporters Criticize Draft China Export Limits
- MARKET ACCESS: United States and Vietnam Reach Bilateral Agreement on WTO Accession Opening Up Vietnam 's Market to U.S. Goods and Services
- EXPORT CONTROLS: New computer control parameter
- EMBARGOS: Oil Concerns Prompt Effort To Relax Cuban Embargo
- PENALTIES: BIS and OFAC Penalties Increase
- EXPORT CONTROLS: Deemed Export Policy Review
- ONLINE ADVERTISING: Operating Through the Borderless Internet Still Requires Compliance with Domestic Laws: Online Advertising—Guidance on Disclosures
Contacts
Insights
Client Alert | 3 min read | 04.07.26
Answering the Top Seven Questions About Pending Section 301 Deadlines
In March 2026, the Office of the United States Trade Representative (USTR) launched two parallel Section 301 investigations: one targeting manufacturing overcapacity across 16 countries (including China, the EU, Japan, India, Mexico, Vietnam, and other major manufactures), and one targeting forced labor enforcement failures across 60 countries. Here are the top seven questions Crowell & Moring’s International Trade team is getting regarding pending Section 301 comment deadlines from our clients and how to address them:
Client Alert | 3 min read | 04.07.26
EU Pharma Package: Fiscal Imports in the Supply Chain Compromise Proposal
Client Alert | 5 min read | 04.07.26
Client Alert | 5 min read | 04.07.26
Weight-Loss Drug Coverage Obligations: A Litigation and Regulatory Update
